Ghana reported first-ever suspected cases of Marburg virus disease
On Jul. 7, 2022, Ghana announced the preliminary finding of two cases of Marburg virus disease and if…
On Jul. 7, 2022, Ghana announced the preliminary finding of two cases of Marburg virus disease and if…
On Jul. 4, 2022, the Democratic Republic of the Congo declared the end of the Ebola outbreak that…
On May 21, 2022, the World Health Organization (WHO) reported that since May 13, 2022, cases of mpox…
On May 21, 2022, the WHO announced that since May 13, 2022, cases of monkeypox had been reported…
On May 19, 2022, WHO issued an emergency use listing (EUL) for CONVIDECIA, a vaccine manufactured by CanSino…
On May 12, 2022, WHOメs COVID-19 Technology Access Pool and the Medicines Patent Pool finalized a licensing agreement…
On May 7, 2022, WHO was informed of a confirmed case of monkeypox in an individual who travelled…
On May 5, 2022, the World Health Organization (WHO) reported estimates that show the full death toll associated…
On Apr. 28, 2022, the Ministry of Health of the Democratic Republic of the Congo declared an outbreak…
On Apr. 22, 2022, the World Health Organization (WHO) made a strong recommendation for nirmatrelvir and ritonavir, sold…
On Mar. 25, 2022, the WHO and the Government of India signed an agreement to establish the WHO…
On Mar. 18, 2022, the World Health Organization (WHO) announced that Malawi had launched the first round of…
On Mar. 4, 2022, the WHO announced it had published an updated position paper on the RTS,S/AS01 (RTS,S)…
On Mar. 3, 2022, the WHO and the Medicines Patent Pool (MPP) jointly welcomed the announcement that the…
On Feb. 22, 2022, Sorrento Therapeutics announced that additional preclinical results demonstrate broad spectrum COVISHIELD (STI-9167) neutralizing activity…
On Feb. 18, 2022, the WHO announced the first six countries that will receive the technology needed to…
On Feb. 11, 2022, Roche announced that Actemraᆴ/RoActemraᆴ (tocilizumab) intravenous (IV) had been granted World Health Organization (WHO)…
On Feb. 11, 2022, the WHO announced the addition of tocilizumab, a monoclonal antibody, to its list of…
On Jan. 28, 2022, the WHO announced that COVID-19 information had reached 1,292,209 people through Viamoメs 3-2-1 Platform…
On Jan. 16, 2022, the WHO announced that it had shipped 1.1 million COVID-19 vaccines to Rwanda on…
On Jan. 14, 2022, the WHO announced that it had recommended two new drugs for COVID-19, providing yet…
On Dec. 20, 2021, Novavax announced that the World Health Organization (WHO) had granted a second Emergency Use…
On Dec. 17, 2021, Novavax and SK bioscience announced that the World Health Organization (WHO) had granted Emergency…
On Dec. 16, 2021, the Ebola outbreak that erupted in the Democratic Republic of the Congo’s North Kivu…
On Dec. 10, 2021, the World Health Organization announced interim recommendations for the use of the Janssen Ad26.COV2.S…
On Nov. 26, 2021, the World Health Organization announced that the Technical Advisory Group on SARS-CoV-2 Virus Evolution…
On Nov. 23, 2021, the World Health Organization’s COVID-19 Technology Access Pool and the Medicines Patent Pool finalized…
On Nov. 10, 2021, the World Health Organization (WHO) announced that while reported measles cases had fallen compared…
On Nov. 4, 2021, Novavax announced the completion of its rolling submission to the World Health Organization (WHO)…
On Nov. 3, 2021, the World Health Organization (WHO) issued an emergency use listing (EUL) for COVAXINᆴ (developed…